Search

everythinglearnresearchcommunity

for

Search:↓

A man with testotoxicosis was fertile despite low FSH levels, suggesting high testosterone may allow sperm production without FSH.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

A 70-year-old woman with a malignant adrenal tumor improved after surgery and radiotherapy.

A woman's hair loss was caused by her husband's testosterone gel and a diabetic man's nail disease led to bone infection, both treated successfully.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Skin changes can indicate starvation and nutritional deficiencies in anorexia nervosa.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

New hair and scalp disease diagnosis methods are important for correct treatment.

Robert T. Leonard Jr. disagrees with Max Rubin's negative views on hair loss treatment, advocating for hormonal tests in women and supporting the use of medications and surgery for androgenetic alopecia.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.